Coating for the guidewires could come off and get left in patients, which could result in extended or additional procedures.

The recall comes more than one year after Medtronic announced it would exit the ventilator market.

Quest plans to refine, develop and validate the technology and is aiming to launch the test in North America next year.

Tandem will integrate its insulin delivery systems with a new dual glucose-ketone sensor being developed by Abbott.

Caris, which offers tools for disease diagnosis, therapy selection and treatment monitoring, is the latest company to test ...